Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
06/09/2004 | CN1152680C Pharmaceutical composition containing liphase inhibitors and chitosan |
06/09/2004 | CN1152678C Pharmaceutical composition comprising lactobacillus plantarum and arginine |
06/09/2004 | CN1152671C Multiple unit pharmaceutical preparation containing proton pump inhibitor |
06/09/2004 | CA2452467A1 Novel methods for the treatment and prevention of pancreatitis and for induction of liver regeneration |
06/08/2004 | US6747045 Such as 1-(3-(((3,4-dihydro-2h-1-benzopyran-2-yl)methyl) amino)-propyl)tetrahydro-2(1h)-pyrimidinone for treatment of irritable bowel syndrome and other gastrointestinal disorders |
06/08/2004 | US6747035 Antiinflammatory agents; antiallergens |
06/08/2004 | US6747034 CRF receptor antagonists and methods relating thereto |
06/08/2004 | US6747032 Pyrimidin-4-one compounds |
06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
06/08/2004 | US6747022 Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same |
06/08/2004 | US6747016 Substituted purine derivatives as inhibitors of cell adhesion |
06/08/2004 | US6747015 Low molecular weight polymannuronate |
06/08/2004 | US6746671 Use of a cytokine-producing lactococcus strain to treat colitis |
06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
06/03/2004 | WO2004046144A1 8-substituted imidazopyridines |
06/03/2004 | WO2004046141A1 New tricyclic angiotensin ii agonists |
06/03/2004 | WO2004046137A1 New tricyclic angiotensin ii agonists |
06/03/2004 | WO2004046135A1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
06/03/2004 | WO2004046134A2 Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation |
06/03/2004 | WO2004046128A1 New bicyclic angiotensin ii agonists |
06/03/2004 | WO2004045718A2 Treatment of cognitive dysfunctions' |
06/03/2004 | WO2004045631A1 The use of psoralea corylifolia for anti-infection caused by helicobacter pylori and for treatment of diseases caused by infection of helicobacter pylori |
06/03/2004 | WO2004045615A1 Palonosetron for the treatment of chemotherapy-induced emesis |
06/03/2004 | WO2004045612A1 Use of a proton pump inhibitor for preventing postoperative nausea and vomiting |
06/03/2004 | WO2004045606A1 Treatment of gastrointestinal disorders with duloxetine |
06/03/2004 | WO2004045594A1 Agent for dissolving dental calculi and dental caries |
06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
06/03/2004 | WO2004019879A3 Motilide compounds |
06/03/2004 | WO2004012726A3 Methods for treatment and prevention of gastrointestinal conditions |
06/03/2004 | WO2003089619A3 Placental derived stem cells and uses thereof |
06/03/2004 | WO2003089450A3 Fusion polypeptides and methods for inhibiting microbial adhesion |
06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
06/03/2004 | WO2003075900A3 Utilization of ubiquinones for influencing the effect of histamine |
06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
06/03/2004 | WO2003048153A8 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
06/03/2004 | US20040106778 Interferon gamma-like protein |
06/03/2004 | US20040106730 Polymer complexes of glucuronoglucanes |
06/03/2004 | US20040106683 show selectivity to the MC1 and MC4 melanocortin receptors as agonists and/or antagonists |
06/03/2004 | US20040106682 Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptors |
06/03/2004 | US20040106675 class of compounds generally called the "statins" for use in stimulating bone formation and method to identify compounds useful in this regard by assessing their ability to inhibit enzymes in the pathway of isoprenoid synthesis |
06/03/2004 | US20040106669 inhibitor against type-X sPLA2 (secretary PLA2) as an active ingredient |
06/03/2004 | US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
06/03/2004 | US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
06/03/2004 | US20040106654 Inhibitors of copper-containing amine oxidases |
06/03/2004 | US20040106643 e.g., (1S,2R,3R,5R)-3-(3,4-Dichlorophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid ethyl ester; |
06/03/2004 | US20040106642 Polysubstituted imidazopyridines as gastric secretion inhibitors |
06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
06/03/2004 | US20040106635 Spiroisoquinoline compound, a method for preparing the same and an intermediate thereof |
06/03/2004 | US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
06/03/2004 | US20040106625 Therapeutic agents useful for treating pain |
06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
06/03/2004 | US20040106610 Antagonize pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins |
06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
06/03/2004 | US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
06/03/2004 | US20040106564 Use of slpi for treating chronic inflammatory intestinal diseases |
06/03/2004 | US20040106561 comprises phytoestrogen isolated from red clover or soya, selected from genistein, daidzein, biochanin A, and/or formononetin; for treatment/prevention of cancer |
06/03/2004 | US20040106559 for inhibiting proteases |
06/03/2004 | US20040106539 Agents for the treatment of viral infections |
06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
06/03/2004 | US20040106155 Method for kidney disease treatment by drug intervention |
06/03/2004 | US20040105862 Human TIMP-1 antibodies |
06/03/2004 | US20040105838 Orlistat compositions |
06/03/2004 | DE10133305B4 Ubichinon Konzentrat Ubiquinone concentrate |
06/03/2004 | CA2506673A1 Treatment of gastrointestinal disorders with duloxetine |
06/03/2004 | CA2506027A1 8-substituted imidazopyridines |
06/02/2004 | EP1424393A2 Mammalian cytokine-like polypeptide-10 |
06/02/2004 | EP1424337A1 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one |
06/02/2004 | EP1424336A1 1,3-benzothiazinone derivatives and use thereof |
06/02/2004 | EP1424335A1 Indole derivatives |
06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
06/02/2004 | EP1424073A1 Anti diarrhoea compositions |
06/02/2004 | EP1424067A1 Injectable foam and novel pharmaceutical applications thereof |
06/02/2004 | EP1423697A2 Secreted proteins |
06/02/2004 | EP1423525A1 Recombinant mva capable of expressing structural hcv antigens |
06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
06/02/2004 | EP1423424A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
06/02/2004 | EP1423415A2 Intracellular signaling molecules |
06/02/2004 | EP1423413A1 Peptidic compounds selectively binding to p-selectin |
06/02/2004 | EP1423409A2 Gastrokines and derived peptides including inhibitors |
06/02/2004 | EP1423406A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
06/02/2004 | EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
06/02/2004 | EP1423382A2 Pyrazole-derived kinase inhibitors and uses thereof |
06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
06/02/2004 | EP1423356A2 Novel aminobenzoephenones |
06/02/2004 | EP1423142A1 Helicobacter pylori vaccination with a combination of caga, vaca and nap proteins |
06/02/2004 | EP1423132A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
06/02/2004 | EP1423126A2 Treatment of hyperproliferative conditions of body surfaces |